Russia facing new wave of drug shortages

23 January 2023

Russia is facing with a new wave of drugs’ shortages and interruptions of supplies due to the ever-tightening sanctions regime against the country and logistics issues, reports The Pharma Letter’s local correspondent.

So far, the Russian authorities have warned of a shortage of drugs in pharmacies - the delivery of some drugs amid the increased demand may be delayed. According to representatives of Russian pharmacies and distributors, there is currently a serious shortage of various drugs from different price categories and market segments.

The government, however, explains the current situation by logistical issues and long holiday periods. In addition, as senior Russian state official have recently reported, 90% of the missing drugs can always be replaced with other drugs, including domestic ones.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK